June 17, 2014 — University Hospitals (UH) Case Medical Center is among the first in the country to offer the BioSense Webster's ThermoCool SmartTouch catheter, the first catheter approved by the U.S. Food and Drug Administration (FDA) to feature direct contact force technology for the treatment of patients with atrial fibrillation.


Interventional thought leaders at an American College of Cardiology (ACC) meeting shared their predictions about the cutting-edge technologies emerging today that will become commonplace in the cath lab of the future. 



C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel provided a unanimous favorable recommendation to FDA for use of the Lutonix Drug Coated Balloon PTA Catheter (DCB) in the United States.


New appropriate use expert consensus documents developed by the Society for Cardiovascular Angiography and Interventions (SCAI) provide guidance on treating the most common form of peripheral artery disease (PAD), namely blockages that affect arteries above the knee. 


June 16, 2014 — PolyNova, a startup company that has grown out of an inter-institutional collaboration between the University of Arizona (UA) and Stony Brook University, announced it is developing a novel polymeric prosthetic heart valve. Sarver Heart Center cardiologist Marvin J. Slepian, M.D., professor of medicine and biomedical engineering at the UA, is the founding CEO of the new venture. PolyNova entered an exclusive option to the patent rights jointly held by the two universities earlier this spring.

June 16, 2014 — Carestream’s Smart Link helps ensure optimal system performance and uptime by continuously monitoring operations of its healthcare IT and digital imaging systems at healthcare providers across the globe. Smart Link is provided as part of Carestream’s customer service maintenance agreements.

Subscribe Now